The MMP-9 C(-1562)T polymorphism T allele was associated with a significantly increased risk of cardiovascular disease in patients with type 2 diabetes (OR 2.87; 95% CI 2.14-3.85; p<0.0001).
Case-Control (n=1,140)
Does the MMP-9 C(-1562)T gene polymorphism increase the risk of cardiovascular disease in patients with Type 2 Diabetes?
The MMP-9 C(-1562)T polymorphism is a significant genetic predictor of cardiovascular disease risk in patients with Type 2 diabetes.
Odds Ratio: 2.87 (95% CI 2.14–3.85)
p-value: p=<0.0001
Matrix metalloproteinase 9 (MMP-9) C(-1562)T gene polymorphism has been considered a risk factor for cardiovascular disease (CVD). Our study aimed to evaluate the association between this polymorphism and CVD in diabetes patients. The genotyping was performed in 740 patients with T2DM and 400 healthy subjects. A significant difference in the polymorphism distribution was revealed between patients and controls. The T allele and TT homozygote were associated with increased risk of diabetes (OR 1.88, p < 0.0001 and OR 3.77, p = 0.0002, respectively). The comparison between CVD+ and CVD− subgroups showed a much higher frequency of the T allele in patients with CVD (OR 2.87, 95% CI 2.14–3.85, p < 0.0001). Patients with the TT genotype had a higher prevalence of CVD (OR 3.19, 95% CI 1.55–6.56, p = 0.0015). The carrier genotypes (CT/TT) were correlated with HDL levels in both CVD+ and CVD− subgroups (p < 0.001 for both). In the logistic regression analysis, only C(-1562)T SNP was a significant predictor of CVD in diabetic patients (p < 0.001). In conclusion, our study suggests an association between MMP-9 C(-1562)T polymorphism and an increased risk of CVD in T2DM. If replicated in other studies, it could be considered a genetic marker for predicting risk of T2DM and its cardiovascular comorbidity.
Buraczyńska et al. (Wed,) conducted a case-control in Type 2 Diabetes and Cardiovascular Disease (n=1,140). MMP-9 C(-1562)T gene polymorphism (T allele) vs. C allele / non-carriers was evaluated on Cardiovascular disease in patients with type 2 diabetes (OR 2.87, 95% CI 2.14-3.85, p=<0.0001). The MMP-9 C(-1562)T polymorphism T allele was associated with a significantly increased risk of cardiovascular disease in patients with type 2 diabetes (OR 2.87; 95% CI 2.14-3.85; p<0.0001).